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Comet tailsLeonardo da Vinci is quoted as saying that simplicity is the ul-
timate sophistication. The truth of this axiom becomes apparent
when considering the original, elegant and, above all, intellectually
and scientiﬁcally sound study published by Saori Majima et al. in
the previous issue of Atherosclerosis [1]. Although using measures
of the function of one of two such distant organs as the kidney and
heart to predict, by correlation, the function or prognosis of the
other may at ﬁrst seem counterintuitive, the authors show that
nevertheless it appears possible. Indeed, in their community-based
cohort, after an adequate period of follow-up, they demonstrate
that electrocardiography PR interval (iPR) and QRS duration (dQRS)
are not only independent predictors of cardiovascular disease and
events e which has long been known e but that they can also be
used to predict a deterioration in renal function.
On the Electrocardiogram (ECG), the PR interval reﬂects atrial
depolarization and atrioventricular node delay, which can be
partially differentiated by P-wave duration and the PR segment,
respectively. It is noteworthy that genetic associations of the PR
interval seem to bemainly driven by genetic determinants of the PR
segment [2]. It has recently been reported that both prolonged PRDOI of original article: http://dx.doi.org/10.1016/j.atherosclerosis.2015.03.001.
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0021-9150/© 2014 Published by Elsevier Ireland Ltd.interval and prolonged QTc (but not prolonged QRS) are indepen-
dently associated with nearly twice the risk of all-cause mortality,
as compared with patients with renal failure without PR or QTc ECG
interval prolongation [3]. This is particularly important since the
cardiological reference measure used in these studies is extremely
cheap, objective, reproducible and not subject to any bias stemming
from operator skill, or lack thereof.
Elsewhere it has been claimed that the erratic, arbitrary, unre-
liable and complex information seemingly provided by lung ul-
trasound artifacts may be suitable for predicting prognosis in
chronic kidney disease patients [4]. In my view, promotion of such
questionable putative markers not only wastes time and money
[5,6], but also represents a step on the slippery slope away from
sound scientiﬁc procedure. It is therefore very timely that Majima
et al. [1] are able to show that the prolongation of ECG PR interval
and, to a lesser extent, the duration of ECG QRS, are the most
powerful predictors of estimated Glomerular Filtration Rate (eGFR)
decline among the variables studied in their multiple regression
analysis. Indeed, they show that neither blood pressure, smoking,
fasting plasma glucose, LDL cholesterol, triglycerides nor uric acid
are signiﬁcant predictors of eGFR decline, but, alongside gender
(male) and high body mass index, the ECG PR interval and duration
of ECG QRS are (Fig. 1).
Of course, this relationship is not proof of causation, but there is
very compelling evidence that both phenotypic changesmay have a
common background of progressive functional impairment. Natu-
rally the relative components are conjectural at this stage, but if
there are common genetic factors, it may be conceivable that they
and more conventional associated risk factors operate through a
shared atherosclerotic pathway. Indeed, the suggestion of a con-
cealed shared mechanism behind the commonly recognized risk
factors for cardiovascular and renal diseases is implicit in these
ﬁndings. Although the Authors acknowledge the lack of sodium,
potassium and calcium serological assays among the limitations of
their study, in my view these factors are not in any case able to
signiﬁcantly affect iPR in normal subjects [7].
Despite the recent major advances in genomic science and
technology having opened new avenues of investigation in the
pathogenesis of coronary heart disease (CHD), some of which are
being translated into clinical practice [8], the complexity of out-
comes and phenotypic indicators are likely to cause uncertainty
Fig. 1. Saori Majima et al. [1] show a convincing link between the progression of renal failure, and hence of glomerular injury, and the duration of the PR interval e the component
of the electrocardiogrammost strongly inﬂuenced by genetic factors [2]. In a ﬁeld where others' attempts to paint castles in the air are increasingly clouding the eye, this novel, fresh
and simple yet sophisticated return to solid, scientiﬁc evidence-gathering helps to clarify the picture and generates much food for thought (drawing by Giuliano Cangiano).
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study (GWAS) ﬁndings. Indeed, thus far the relative contributions of
common variants of modest effect, and rare variants of greater ef-
fects, in terms of the risk of CHD or response to drugs remain un-
clear [8]. It is refreshing then that, despite its apparently simplicity,
the use of recorded ECG intervals [1], which are mainly modulated
by heart rate [2,7] and are not subject to arbitrary interpretation,
appear to indicate a fruitful area of research.
Though there is concern that awareness of the role of genetics in
the aetiology of chronic disease may undermine efforts to improve
lifestyle, and therefore adversely affect public health, the in-
teractions between genetics, lifestyle and environment cannot be
ignored. In fact, there is evidence that recognition of the inﬂuence
of genetics on chronic disease risk can prompt individuals to
reassess their lifestyles, ﬂying in the face of the belief that the
public takes an ‘either/or’ approach to such potentially preventable
diseases [9]. Hence the genetic “threat”, if used appropriately as an
easy-to-obtain surrogate marker, could be seen as a pivotal tool for
empowering lifestyle changes and modiﬁcation of dietary and
exercising habits [10,11].
Therefore, unlike the “red herrings” furnished by woolly criteria
or procedures, which may be prejudicial to more robust and reli-
able approaches [5,6], this ﬁnding by Majima et al. [1] is a welcome
step in the right direction. Indeed, it is only thorough, scientiﬁcally
sound investigation that will elucidate the shared basis of such
pathologies, enabling us to raise awareness about the role of co-
morbidities in chronic disease, and foster the development of tar-
geted and effective clinical practice.References
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